| 000 | 01789 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516142110.0 | ||
| 264 | 0 | _c20140121 | |
| 008 | 201401s 0 0 fre d | ||
| 022 | _a1953-8022 | ||
| 024 | 7 |
_a10.1016/j.tracli.2013.02.009 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartinaud, C | |
| 245 | 0 | 0 |
_a[Therapeutic plasmas available worldwide]. _h[electronic resource] |
| 260 |
_bTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _cMay 2013 |
||
| 300 |
_a255-60 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aBlood Component Transfusion _xstatistics & numerical data |
| 650 | 0 | 4 | _aBlood Donors |
| 650 | 0 | 4 | _aBlood Preservation |
| 650 | 0 | 4 | _aBlood Safety |
| 650 | 0 | 4 | _aCommerce |
| 650 | 0 | 4 |
_aDetergents _xpharmacology |
| 650 | 0 | 4 | _aDisasters |
| 650 | 0 | 4 | _aFrance |
| 650 | 0 | 4 | _aFreeze Drying |
| 650 | 0 | 4 |
_aFurocoumarins _xpharmacology |
| 650 | 0 | 4 | _aGlobal Health |
| 650 | 0 | 4 | _aHealth Services Needs and Demand |
| 650 | 0 | 4 |
_aHemorrhage _xtherapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeukocyte Reduction Procedures _xstatistics & numerical data |
| 650 | 0 | 4 |
_aMethylene Blue _xpharmacology |
| 650 | 0 | 4 | _aMicrobial Viability |
| 650 | 0 | 4 |
_aPhotosensitizing Agents _xpharmacology |
| 650 | 0 | 4 | _aPlasma |
| 650 | 0 | 4 |
_aRiboflavin _xpharmacology |
| 650 | 0 | 4 |
_aSolvents _xpharmacology |
| 650 | 0 | 4 | _aUltraviolet Rays |
| 650 | 0 | 4 | _aWarfare |
| 650 | 0 | 4 | _aWorld Health Organization |
| 700 | 1 | _aCauet, A | |
| 700 | 1 | _aSailliol, A | |
| 773 | 0 |
_tTransfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine _gvol. 20 _gno. 2 _gp. 255-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.tracli.2013.02.009 _zAvailable from publisher's website |
| 999 |
_c22608595 _d22608595 |
||